Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

September 01, 1989; Volume 250,Issue 3
  • You have access
    A stereoselective central hypotensive action of atenolol.
    A A Pearson, T E Gaffney, T Walle and P J Privitera
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 759-763;
  • You have access
    Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat.
    D D Schwartz and K U Malik
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 764-771;
  • You have access
    In vitro evidence that urine composition affects the fraction of active furosemide in the nephrotic syndrome.
    J R Voelker, D M Jameson and D C Brater
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 772-778;
  • You have access
    Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital.
    S M Evans and C E Johanson
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 779-787;
  • You have access
    Acute and chronic effects of corticotropin-releasing factor on schedule-controlled responding and neurochemistry of pigeons.
    J E Barrett, L Zhang, S T Ahlers and F H Wojnicki
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 788-794;
  • You have access
    Inhibition of bradykinin-induced increases of cytosolic Ca++ by a novel amiloride analog.
    D W Coyne, M Mordhorst, E J Cragoe and A R Morrison
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 795-799;
  • You have access
    Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    D A Cory-Slechta, D V Widzowski and M C Newland
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 800-808;
  • You have access
    Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes.
    S Gleeson, S T Ahlers, R S Mansbach, J M Foust and J E Barrett
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 809-817;
  • You have access
    Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
    S P Sivam
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 818-824;
  • You have access
    Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide.
    M S Fanselow, D J Calcagnetti and F J Helmstetter
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 825-830;
  • You have access
    Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    W J Morrison and S D Shukla
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 831-835;
  • You have access
    Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
    R W Tuman, C R Bowden, M Inman, N Altszuler and G F Tutwiler
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 836-841;
  • You have access
    The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects.
    M Alkondon and E X Albuquerque
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 842-852;
  • You have access
    Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
    D J Friedman, D Budai, D N Krause and S P Duckles
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 853-859;
  • You have access
    Differential association of T-2 and T-2 tetraol with mammalian cells.
    J L Middlebrook and D L Leatherman
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 860-866;
  • You have access
    Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
    A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;
  • You have access
    Ethanol and inositol 1,4,5-trisphosphate release calcium from separate stores of brain microsomes.
    L C Daniell and R A Harris
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 875-881;
  • You have access
    Blockade of epidermal growth factor-induced uterine contractions by indomethacin or nordihydroguaritic acid.
    R M Gardner and G M Stancel
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 882-886;
  • You have access
    Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
    G A Kopia, L J Kopaciewicz, E H Ohlstein, S Horohonich, B L Storer and R J Shebuski
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 887-895;
  • You have access
    Mechanism of cyclosporine A-induced renal vasoconstriction in the rat.
    N F Rossi, P C Churchill, F D McDonald and V R Ellis
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 896-901;
  • You have access
    Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
    J H Mendelson, N K Mello, S K Teoh and J Ellingboe
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 902-909;
  • You have access
    Effect of phthalate acid esters on transport in toad bladder membrane.
    S Sabatini, A Fracasso, G Bazzato and N A Kurtzman
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 910-914;
  • You have access
    Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord.
    M Sosnowski, C W Stevens and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 915-922;
  • You have access
    Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.
    P R Mayeux, D E Mais, C Carr and P V Halushka
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 923-927;
  • You have access
    Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys.
    C P France and W H Morse
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 928-936;
  • You have access
    Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
    C P France and J H Woods
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 937-943;
  • You have access
    Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    T Kenakin and C Boselli
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 944-952;
  • You have access
    Is L-glutamate a neurotransmitter of baroreceptor information in the nucleus of the tractus solitarius?
    C Leone and F J Gordon
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 953-962;
  • You have access
    Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
    A I Nichols, R D'Ambrosio, N A Pyszczynski and W J Jusko
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 963-970;
  • You have access
    Comparison of contractions to serotonin, carbamylcholine and prostaglandin F2 alpha in rat stomach fundus.
    R J Secrest, D D Schoepp and M L Cohen
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 971-978;
  • You have access
    Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
    H Suzuki, Y Sawada, Y Sugiyama, T Iga, M Hanano and R Spector
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 979-984;
  • You have access
    Are changes in neuronal calcium channels involved in ethanol tolerance?
    S J Dolin and H J Little
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 985-991;
  • You have access
    Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
    S P Salas, J Roblero, H Ureta and J P Huidobro-Toro
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 992-999;
  • You have access
    Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons.
    T U Järbe, A J Hiltunen and R Mechoulam
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1000-1005;
  • You have access
    Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
    M Gué, J L Junien and L Bueno
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1006-1010;
  • You have access
    Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets.
    P Lebrun, V Devreux, M Hermann and A Herchuelz
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1011-1018;
  • You have access
    The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
    W Koek, F C Colpaert, J H Woods and J M Kamenka
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1019-1027;
  • You have access
    Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
    P T Männistö, H Hanhijärvi, A Havas, A Vuorela, H Komulainen and V Rauramaa
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1028-1033;
  • You have access
    Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
    G Labbe, V Descatoire, P Beaune, P Letteron, D Larrey and D Pessayre
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1034-1042;
  • You have access
    Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.
    P W Angus, G W Mihaly, D J Morgan and R A Smallwood
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1043-1047;
  • You have access
    Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
    M S Ching, D J Morgan and R A Smallwood
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1048-1054;
  • You have access
    Possible involvement of 5-lipoxygenase products in the generation of endothelium-derived relaxing factor.
    Y Minami and N Toda
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1055-1060;
  • You have access
    Obesity modifies the adrenergic status of dog adipose tissue.
    M Taosis, P Valet, L Estan, M Lafontan, P Montastruc and M Berlan
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1061-1066;
  • You have access
    Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
    W Löscher, J E Fisher, H Nau and D Hönack
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1067-1078;
  • You have access
    Inhibitory actions of a novel benzothiazepine derivative, TA3090, on the electrical and mechanical responses of the rabbit mesenteric artery.
    E Nishiye, K Nakao, K Kitamura and H Kuriyama
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1079-1086;
  • You have access
    Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart.
    T Musha, E Satoh, H Koyanagawa, T Kimura and S Satoh
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1087-1091;
  • You have access
    Inhibition of vagal transmission by cardiac sympathetic nerve stimulation in the dog: possible involvement of opioid receptor.
    H Koyanagawa, T Musha, A Kanda, T Kimura and S Satoh
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1092-1096;
  • You have access
    Role of lipoxygenase, cyclooxygenase and cytochrome P-450 metabolites in contractions of isolated guinea pig pulmonary venules induced by hypoxia and anoxia.
    W R Tracey, J R Bend, J T Hamilton and N A Paterson
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1097-1104;
  • You have access
    Cyclosporine treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstrictors and endothelium-dependent dilators.
    J F Gerkens
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1105-1112;
  • You have access
    Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
    J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;
  • You have access
    Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.
    A G Shi, C Y Kwan and E E Daniel
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1119-1124;
  • You have access
    Effects of endothelin on regional blood flows in squirrel monkeys.
    M Clozel and J P Clozel
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1125-1131;
  • You have access
    Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line.
    M Miyamoto, T H Murphy, R L Schnaar and J T Coyle
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1132-1140;
  • You have access
    Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes.
    S F Steinberg, L M Kaplan, T Inouye, J F Zhang and R B Robinson
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1141-1148;
  • You have access
    Solubilization and characterization of the liver peripheral-type benzodiazepine receptor.
    A L Parola, C W Putnam, D H Russell and H E Laird
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1149-1155;
  • You have access
    D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
    J M Trugman, W S Arnold, N Touchet and G F Wooten
    Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1156-1160;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 250, Issue 3
1 Sep 1989
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Nose-to-Brain Delivery
  • Interaction between Bupropion and MDMA
  • Smoking Could Worsen COVID-19 Outcome
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics